Anticoagulation treatment of cancer patients with deep or superficial leg vein thrombosis - a retrospective observational study of German statutory health insurance claims data (the CERTIFICAT initiative).

Schellong, S; Kretzschmar, A; Heinken, A; May, M; Kolbe, K; Schreiber, S; Riess, H

Schellong, S; Kretzschmar, A; Heinken, A; May, M; Kolbe, K; Schreiber, S; Riess, H.

Afiliación

Schellong S; Medical Clinic Department for Cardiovascular Disease, Städtisches Klinikum Dresden, Germany.
Kretzschmar A; Department for Haematology and Internist Oncology, Klinikum St. Georg, Leipzig, Germany.
Heinken A; Aspen Germany GmbH, Munich, Germany.
May M; HGC Healthcare Consultants GmbH, Duesseldorf, Germany.
Kolbe K; HGC Healthcare Consultants GmbH, Duesseldorf, Germany.
Schreiber S; HGC Healthcare Consultants GmbH, Duesseldorf, Germany.
Riess H; Medical Department, Division of Oncology and Hematology, Campus Charité Mitte, Charité Universitätsmedizin Berlin, Germany.

Vasa ; 49(5): 403-409, 2020 Aug.

Article en En | MEDLINE | ID: mdl-32520658

Asunto(s)

Anticoagulantes/uso terapéutico; Trombosis; Alemania; Heparina de Bajo-Peso-Molecular; Humanos; Seguro de Salud; Pierna; Calidad de Vida; Estudios Retrospectivos; Trombosis/tratamiento farmacológico

Palabras clave

CAT; CERTIFICAT; German; SHI claims data; Thrombo; cancer-associated thrombo

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Trombosis / Anticoagulantes Tipo de estudio: Guideline / Observational_studies / Risk_factors_studies Límite: Humans País/Región como asunto: Europa Idioma: En Revista: Vasa Año: 2020 Tipo del documento: Article País de afiliación: Alemania

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google